Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2018 · 10-Q
Revenue$144.61M$144.61M+10.7% vs Q1 2017 Net Income$15.86M$15.86M−15.8% vs Q1 2017 EPS Diluted$0.42$0.42−16.0% vs Q1 2017 Gross Profit$97,868,000+12.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$44,696,000+68.7% Free Cash Flowderived$39,423,000+63.9% Margins · derivedGross margin67.7%+0.8 pt vs Q1 2017
Operating margin18.0%−4.3 pt vs Q1 2017
Net margin11.0%−3.5 pt vs Q1 2017
ended Sep 30, 2017 · filed Nov 9, 2017 · 40 d after period end